quality of care

Interview

Clinical Pathways and Value-Based Care at the Dana Farber Cancer Institute

08/03/2017

JCP Editors

Journal of Clinical Pathways spoke with Aymen Elfiky, MD, MPH, MSc, attending physician, clinical oncology, Dana Farber Cancer Institute (Boston, MA), about clinical pathway implementation at the Institute,...

...

08/03/2017

Journal of Clinical Pathways

Research in Review

Clinical Trial Efficacy Consistent with Real-World Outcomes, Study Shows

07/28/2017

JCP Editors

Researchers compared the relationship between randomized controlled clinical trial efficacy data and real-world effectiveness for oncology therapies, published in Value in Health (July-August,...

...

07/28/2017

Journal of Clinical Pathways

Research in Review

ADT Plus Combination Therapy Improves Outcomes in Metastatic Prostate Cancer

07/28/2017

JCP Editors

A combination regimen plus androgen-deprivation therapy prolongs overall survival (OS) and radiographic progression-free survival (PFS) in newly diagnosed patients with metastatic, castration-sensitive prostate...

A...

07/28/2017

Journal of Clinical Pathways

Research in Review

Second TKI Discontinuation Attempt Safe in Patients With CML

07/27/2017

JCP Editors

Patients with chronic myeloid leukemia (CML) who attempt to discontinue tyrosine kinase inhibitor (TKI) therapy for a second time after a first unsuccessful attempt have strong treatment-free remission rates,...

...

07/27/2017

Journal of Clinical Pathways

Research in Review

Cancer Symptoms More Important Than Diagnosis for Palliative Care

07/27/2017

JCP Editors

Results of a recent survey showed that for patients with cancer requiring palliative care, some symptoms and care needs are not strongly associated with specific diagnoses, published in Supportive Care in Cancer...

...

07/27/2017

Journal of Clinical Pathways

Research in Review

High-Priority Areas for Quality Improvement Identified for Breast Cancer Treatment

07/26/2017

JCP Editors

Researchers identified three quality measures that have the largest potential of improving quality of care at a system level for patients with early-stage breast cancer receiving systemic therapy. ----- Related...

...

07/26/2017

Journal of Clinical Pathways

Research in Review

Multidisciplinary Quality Measures Identified for Head and Neck Cancer

07/24/2017

JCP Editors

Researchers have identified five quality metrics to help improve head and neck cancer care, published in Cancer (online July 20, 2017; doi:10.1002/cncr.30902). ----- Related Content Quality Measures for NSCLC...

...

07/24/2017

Journal of Clinical Pathways

Research in Review

Immunotherapy Diminishes Regulatory T-Cells, Improves Outcomes in AML

07/20/2017

JCP Editors

Immunotherapy after complete remission in acute myeloid leukemia (AML) is associated with decreasing levels of regulatory T-cells, which leads to favorable clinical outcomes, according to research published in Cancer...

...

07/20/2017

Journal of Clinical Pathways

Research in Review

Is Active Surveillance Beneficial for Patients With Intermediate-Risk Prostate Cancer?

07/20/2017

JCP Editors

Recent research explored the potential of a subset of patients with intermediate-risk prostate cancer likely to benefit from active surveillance. Active surveillance is currently recommended for patients with...

Recent...

07/20/2017

Journal of Clinical Pathways

Research in Review

New Therapy Highly Effective in Treatment-Resistant CLL

07/18/2017

JCP Editors

A recent study reported an overall response rate (ORR) of 71% in patients with chronic lymphocytic leukemia (CLL) treated with anti-CD19 chimeric antigen receptor-modified T (CAR-T) cell therapy after prior treatment...

A...

07/18/2017

Journal of Clinical Pathways